Lee B J, Cui J H, Kim T W, Heo M Y, Kim C K
Biological Rhythm and Controlled Release Lab., College of Pharmacy, Kangwon National University, Chuncheon, Korea.
Arch Pharm Res. 1998 Dec;21(6):645-50. doi: 10.1007/BF02976751.
The dual drug-loaded alginate beads simultaneously containing drug in inner and outer layers were prepared by dropping plain (single-layered) alginate beads into CaCl2 solution. The release characteristics were evaluated in simulated gastric fluid for 2 h followed by intestinal fluids thereafter for 12 h. The surface morphology and cross section of dual drug-loaded alginate beads was also investigated using scanning electron microscope (SEM). The poorly water-soluble ibuprofen was chosen as a model drug. The surface of single-layered and dual drug-loaded alginate beads showed very crude and roughness, showing aggregated particles, surface cracks and rough crystals. The thickness of dual drug-loaded alginate beads surrounded by outer layer was ranged from about 57 to 329 microns. The distinct chasm between inner and outer layers was also observed. In case of single-layered alginate beads, the drug was not released in gastric fluid but was largely released in intestinal fluid. However, the release rate decreased as the reinforcing Eudragit polymer contents increased. When the plasticizers were added into polymer, the release rate largely decreased. The release rate of dual drug-loaded alginate beads was stable in gastric fluid for 2 h but largely increased when switched in intestinal fluid. The drug linearly released for 4 h followed by another linear release thereafter, showing a distinct biphasic release characteristics. There was a difference in the release profiles between single-layered and dual drug-loaded alginate beads due to their structural shape. However, this biphasic release profiles were modified by varying formulation compositions of inner and outer layer of alginate beads. The release rate of dual drug-loaded alginate beads slightly decreased when the outer layer was reinforced with Eudragit RS100 polymers. In case of dual drug-loaded alginate beads with polymer-reinforced outer layer only, the initial amount of drug released was low but the initial release rate (slope) was higher due to more swellable inner cores when compared to polymer-reinforced inner cores. The current dual drug-loaded alginate beads may be used to deliver the drugs in a time dependent manner.
通过将普通(单层)海藻酸钠珠滴入氯化钙溶液中,制备了同时在内层和外层含有药物的双载药海藻酸钠珠。在模拟胃液中评估2小时的释放特性,随后在肠液中评估12小时的释放特性。还使用扫描电子显微镜(SEM)研究了双载药海藻酸钠珠的表面形态和横截面。选择难溶性布洛芬作为模型药物。单层和双载药海藻酸钠珠的表面显示出非常粗糙和不平,呈现出聚集颗粒、表面裂纹和粗糙晶体。被外层包围的双载药海藻酸钠珠的厚度范围约为57至329微米。还观察到内层和外层之间有明显的裂缝。对于单层海藻酸钠珠,药物在胃液中不释放,但在肠液中大量释放。然而,随着增强型丙烯酸树脂聚合物含量的增加,释放速率降低。当向聚合物中加入增塑剂时,释放速率大幅降低。双载药海藻酸钠珠在胃液中2小时内释放速率稳定,但切换到肠液中时大幅增加。药物先线性释放4小时,然后再线性释放,呈现出明显的双相释放特性。由于其结构形状,单层和双载药海藻酸钠珠的释放曲线存在差异。然而,通过改变海藻酸钠珠内层和外层的配方组成,可以改变这种双相释放曲线。当外层用丙烯酸树脂RS100聚合物增强时,双载药海藻酸钠珠的释放速率略有降低。对于仅外层用聚合物增强的双载药海藻酸钠珠,与聚合物增强的内核相比,由于内核更易膨胀,药物的初始释放量较低,但初始释放速率(斜率)较高。当前的双载药海藻酸钠珠可用于以时间依赖性方式递送药物。